Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Curanex Pharmaceuticals Inc. ( (CURX) ) has issued an update.
On September 25, 2025, Curanex Pharmaceuticals Inc. issued 28,312 shares of common stock to investor Xiaohong Song as part of an Amended and Restated Subscription Agreement, following the company’s initial public offering (IPO) on August 27, 2025. The issuance was part of a broader IPO effort where the company issued a total of 4,312,500 shares, including an over-allotment option. Additionally, the company repaid two promissory notes to Dian Ying Jing, totaling $408,537.32, which eliminated its outstanding debt and saved approximately $26,182.68 in future interest charges.
More about Curanex Pharmaceuticals Inc.
Curanex Pharmaceuticals Inc. is a Nevada-based company operating in the pharmaceutical industry. It primarily focuses on developing and distributing pharmaceutical products, although specific market focus or primary products are not detailed in the release.
Average Trading Volume: 4,593,666
For an in-depth examination of CURX stock, go to TipRanks’ Overview page.